PolySciTech division of
Akina, Inc (www.polyscitech.com)
provides a wide array of biodegradable polyesters including
poly(lactide-co-glycolide) PLGA and related polymers. One of the common usages
for this polymer is to use it for encapsulating a medicinal molecule inside and
generating a micron sized spheres of PLGA (microspheres or microparticles)
which can be directly injected into a patient via typical syringe and needle
either intra-muscular or subcutaneous. Over time, the PLGA microparticles
slowly releases the medicine into the patient’s blood-stream ideally
maintaining the medicinal concentration within the therapeutic window (above
the effective dose but below the toxic dose) over an extended course of time
(weeks to months). Afterwards, the PLGA degrades into its nontoxic components
lactic and glycolic acid and is naturally metabolized by the body. This
delivery system is currently used for a variety of clinical formulations
(Risperdal Consta®, Trelstar ®, and several others) so that there is no need
for the patient to receive daily injections to maintain a therapeutic dose. The
release mechanism is known to be a combination of diffusion of the drug through
the PLGA matrix out into the blood-stream as well as the degradation of the
polymer which contributes to drug release from PLGA microparticles. However,
not all of these complex and overlapping processes are fully understood in a
mechanistic sense. Without this understanding, development to drug delivery
microparticles still require a great deal of trial-and-error. Recently, one of
the most in-depth mechanistic studies to date regarding the PLGA controlled
delivery of medicines has been reported by researchers at the University of
Connecticut. Here they trapped the PLGA microspheres in a PVA hydrogel and
imaged them in sequence during drug release and degradation. They correlated
these results to polymer physicochemical properties to elucidate parameters
which affect release in a micro-environment setting. They managed to track several
complex and overlapping interactions including pore-formation and closure,
microclimate acidification, water uptake, and microdialysis. You can learn more
about these fascinating processes that affect PLGA microparticle performance
here: Gu, Bing, Xuanhao Sun, Fotios Papadimitrakopoulos, and Diane J. Burgess.
"Seeing is believing, PLGA microsphere degradation revealed in PLGA
microsphere/PVA hydrogel composites." Journal of Controlled Release
(2016). http://www.sciencedirect.com/science/article/pii/S0168365916301353
Blog dedicated to answering technical questions in an open format relating to PolySciTech (A division of Akina, Inc.) products.
Tuesday, March 15, 2016
PLGA microparticle drug delivery elucidated by in-depth mechanistic study
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment